Your session is about to expire
← Back to Search
[18F]FLOR PET/CT Imaging for Prostate Cancer
Study Summary
This trial is testing how well a new imaging technique can detect prostate cancer that has spread to other parts of the body.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: [18F]FLOR (FC303)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people have enrolled in this experimental research protocol?
"Correct. According to the information hosted on clinicaltrials.gov, this medical trial is actively searching for 10 volunteers, who can be found at 2 different sites. The study was initially posted on February 1st 2021 and most recently updated on December 14th 2021."
Are there any current opportunities for enrolment in this trial?
"The clinical trial, initially posted on February 1st 2021 according to the data available at clinicaltrials.gov, is currently seeking participants. The details of this study have been most recently updated on December 14th 2021."
How has [18F]FLOR (FC303) Injection been proven to be secure for patients?
"[18F]FLOR (FC303) Injection has been allocated a 1 on the safety scale by our Power team, signifying that there is limited data to demonstrate its efficacy and protectiveness."
Share this study with friends
Copy Link
Messenger